Loren Data's SAM Daily™

FBO DAILY ISSUE OF MAY 08, 2002 FBO #0157
SOLICITATION NOTICE

66 -- FACSVantage SE cell sorter data acquisition system

Notice Date

5/6/2002
 

Notice Type

Solicitation Notice
 

Contracting Office

Department of Health and Human Services, National Institutes of Health, National Cancer Institute, Research Contracts Br., 6120 Executive Blvd. EPS Room 604, Rockville, MD, 20852
 

ZIP Code

20852
 

Solicitation Number

NCI-20045-NG
 

Response Due

5/21/2002
 

Archive Date

6/5/2002
 

Point of Contact

Malinda Holdcraft, Purchasing Agent, Phone (301) 402-4509, Fax (301) 402-4513, - Caren Rasmussen, Lead Contract Specialist, Phone (301) 402-4509, Fax (301) 402-4513,
 

E-Mail Address

holdcram@exchange.nih.gov, rasmusc@mail.nih.gov
 

Description

The National Cancer Institute (NCI), Center for Cancer Research (CCR), Experimental Transplantation and Immunology Branch (ETIB), plans to procure a BD Biosciences FACSVantage SE cell sorter with Digital Vantage (DiVa) digital data acquisition system from Becton Dickinson Biosciences, Inc., 2350 Qume Drive, San Jose, CA 95131. The supplies and services herein are commercial as defined in FAR Part 12, and this acquisition is being made in accordance with the test program for using simplified procedures for certain commercial items as authorized in FAR Part 13.5. The North American Industry Classification System code is 421450 and the business size standard is 100 employees. The NCI ETIB Flow Cytometry Core Facility provides essential optical biology services to the Branch and to other investigators in the NCI and NIH. The core is committed to maintaining an up-to-date array of instrumentation for its investigators. The core currently possesses a 1998 BD Biosciences FACSVantage SE cell sorter for physical separation of a wide variety of cell types required by our investigators. This instrument receives heavy use by both Branch and outside investigators. NCI has the opportunity to upgrade this instrument in two significant ways: 1st, through conversion of the instrument to full digital acquisition electronics (the Digital Vantage, or DiVa), and 2nd, through the addition of four additional fluorescent detectors, bring our simultaneous fluorescent probe analysis capability from 6 to 12. The first upgrade shall enhance both the analysis and sorting speed of our instrument, and allow NCI to sort up to four subpopulations simultaneously (up from our current two). The second upgrade shall increase both the number of fluorochromes NCI can analyze simultaneously, and the flexibility with which NCI can design complex fluorescent experiments. The BD Biosciences DiVa and 12-color optical bench upgrades will substantially enhance the flow cytometric analysis capabilities of NCI and NIH scientists, both within the ETI Branch and the CCR/NCI. NCI believes there are no other instruments on the market that can match its complete conversion to digital data acquisition and sorting control or its number of available fluorescent detectors (up to twelve). This is not a solicitation for competitive quotations. However, if any interested party believes it can meet the above requirement, they may submit a statement of capabilities. All information furnished shall be in writing and must contain sufficient detail to allow the NCI to determine if it can meet the above unique specifications described herein. Capability statements must be received in the Contracting Office by 1:00 PM EDT (local Washington, D.C. time) on May 21, 2002. If you have any questions, please submit them in writing via electronic mail to Malinda Holdcraft at holdcram@exchange.nih.gov. A determination by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement. No collect calls will be accepted. No faxed copies of capability statements will be accepted. Interested parties are required to mail one (1) original and two (2) copies of the capability statements to the following address: Malinda Holdcraft, NIH/NCI/RCB, 6120 Executive Blvd. Suite 6072, Rockville, Maryland 20852-7194.
 

Place of Performance

Address: NIH/NCI, 9000 Rockville Pike, Bethesda,Maryland

Zip Code: 20892

Country: USA
 

Record

SN00072032-W 20020508/020506213209 (fbodaily.com)
 

Source

FedBizOpps.gov Link to This Notice
(may not be valid after Archive Date)

---

| FSG Index  |  This Issue's Index  |  Today's FBO Daily Index Page |